Gla-rich protein is a novel vitamin K-dependent protein present in serum that accumulates at sites of pathological calcifications

American Journal of Pathology

Volumn 175, Issue 6, 2009, Pages 2288-2298

  Viegas, Carla S B ^a   Cavaco, Sofia ^a   Neves, Pedro L ^b   Ferreira, Ana ^c   João, Alexandre ^c   Williamson, Matthew K ^d   Price, Paul A ^d   Cancela, M Leonor ^a   Simes, Dina C ^a,c  

^a UNIVERSITY OF ALGARVE   (Portugal)

^b Hospital Faro   (Portugal)

^c Central Lisbon Hospital Centre   (Portugal)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MINERAL; OSTEOCALCIN; PROTEIN; VITAMIN K GROUP;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CARDIOVASCULAR SYSTEM; CARTILAGINOUS TISSUE; CONNECTIVE TISSUE; DISEASE ASSOCIATION; GENE EXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MINERALIZATION; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SERUM; SKIN; SOFT TISSUE; SOFT TISSUE CALCIFICATION;

EID: 73549121071     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090474     Document Type: Article

References (42)

1. Schinke T, McKee MD, Karsenty G: Extracellular matrix calcification: where is the action? Nat Genet 1999, 21:225-229
2. Giachelli CM: Ectopic calcification: gathering hard facts about soft tissue mineralization. Am J Pathol 1999, 154:671-675
3. Wallin R, Wajih N, Greenwood GT, Sane DC: Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy. Med Res Rev 2001, 21:274-301
4. Danziger J: Vitamin K-dependent proteins, warfarin, and vascular calcification. Clin J Am Soc Nephrol 2008, 3:1504-1510
5. Cranenburg EC, Schurgers LJ, and Vermeer C: Vitamin K: the coagulation vitamin that became omnipotent. Thromb Haemost 2007, 98:120-125
6. Gheduzzi D, Boraldi F, Annovi G, DeVincenzi CP, Schurgers LJ, Vermeer C, Quaglino D, Ronchetti IP: Matrix Gla protein is involved in elastic fiber calcification in the dermis of pseudoxanthoma elasticum patients. Lab Invest 2007, 87:998-1008
7. Li Q, Jiang Q, Schurgers LJ, Uitto J: Pseudoxanthoma elasticum: reduced gammaglutamyl carboxylation of matrix gla protein in a mouse model (Abcc6-/-). Biochem Biophys Res Commun 2007, 364:208-213
8. Hendig D, Zarbock R, Szliska C, Kleesiek K, Gö tting C: The local calcification inhibitor matrix Gla protein in pseudoxanthoma elasticum. Clin Biochem 2008, 41:407-412
9. Davies CA, Jeziorska1 M, Freemont AJ, Herrick AL: Expression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis. Rheumatology 2006, 45:1349-1355
10. Price PA, Faus SA, Williamson MK: Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998, 18:1400-1407
11. Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C: Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 2007, 109:2823-2831
12. Schurgers LJ, Spronk HM, Skepper JN, Hackeng TM, Shanahan CM, Vermeer C, Weissberg PL, Proudfoot D: Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J Thromb Haemost 2007, 5:2503-2511
13. Li Q, Jiang Q, Pfendner E, Vá radi A, Uitto J: Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms. Exp Dermatol 2009, 18:1-11
14. Li Q, Schurgers LJ, Smith AC, Tsokos M, Uitto J, Cowen EW: Coexistent pseudoxanthoma elasticum and vitamin K-dependent coagulation factor deficiency: compound heterozygosity for mutations in the GGCX gene. Am J Pathol 2009, 174:534-540
15. Vanakker OM, Martin L, Gheduzzi D, Leroy BP, Loeys BL, Guerci VI, Matthys D, Terry SF, Coucke PJ, Pasquali-Ronchetti I, De Paepe A: Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity. J Invest Dermatol 2007, 127:581-587
16. Nanda A, Anim JT, Al-Gareeb M, Alsaleh QA: Keutel syndrome with overlapping features of cutis laxa: a new variant. Am J Med Genet A 2006, 140:1487-1489
17. Boer-van den Berg MA, Verstijnen CP, Vermeer C: Vitamin K-dependent carboxylase in skin. J Invest Dermatol 1986, 87:377-380
18. Viegas CS, Simes DC, Laizé V, Williamson MK, Price PA, Cancela ML: Gla-rich Protein (GRP), a new vitamin K-dependent protein identified from sturgeon cartilage and highly conserved in vertebrates. J Biol Chem 2008, 283:36655-36664
19. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
20. Ortiz-Delgado JB, Simes DC, Viegas CS, Schaff BJ, Sarasquete C, Cancela ML: Cloning of matrix Gla protein in a marine cartilaginous fish. Prionace glauca: preferential protein accumulation in skeletal and vascular systems. Histochem Cell Biol 2006, 126:89-101
21. Simes DC, Williamson MK, Delgado JBO, Viegas CSB, Price PA, Cancela ML: Purification of Matrix Gla protein (MGP) from a marine teleost fish. Argyrosomus regius: calcified cartilage and not bone as the primary site of MGP accumulation in fish. J Bone Min Res 2003, 18:244-259
22. Simes DC, Williamson MK, Schaff BJ, Gavaia PJ, Ingleton PM, Price PA, Cancela ML: Characterization of osteocalcin (BGP) and matrix Gla protein (MGP) fish specific antibodies: validation for immunodetection studies in lower vertebrates. Calcif Tissue Int 2004, 74:170-180
23. Cranenburg EC, Vermeer C, Koos R, Boumans ML, Hackeng TM, Bouwman FG, Kwaijtaal M, Brandenburg VM, Ketteler M, Schurgers LJ: The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res 2008, 45:427-436
24. Price PA, Nguyen TM, Williamson MK: Biochemical characterization of the serum fetuin-mineral complex. J Biol Chem 2003, 278:22153-22160
25. Surmann-Schmitt C, Dietz U, Kireva T, Adam N, Park J, Tagariello A, Onnerfjord P, Heinegard D, Schlötzer-Schrehardt U, Deutzmann R, von der Mark K, and Stock M: Ucma, a novel secreted cartilage-specific protein with implications in osteogenesis. J Biol Chem 2008, 283:7082-7093
26. Moe SM, Chen NX: Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 2004, 95:560-567
27. Lian JB, Skinner M, Glimcher MJ, Gallop P: The presence of gamma-carboxyglutamic acid in the proteins associated with ectopic calcification. Biochem Biophys Res Commun 1976, 73:349-355
28. Lian JB, Boivin G, Patterson-Allen P, Grynpas M, Walzer C: Calcergy and calciphylaxis: timed appearance of gamma-carboxyglutamic acid and osteocalcin in mineral deposits. Calcif Tissue Int 1983, 35:555-561
29. Berger RG, Featherstone GL, Raasch RH, McCartney WH, Hadler NM: Treatment of calcinosis universalis with low-dose warfarin. Am J Med 1987, 83:72-76
30. Cukierman T, Elinav E, Korem M, Chajek-Shaul T: Low dose warfarin treatment for calcinosis in patients with systemic sclerosis. Ann Rheum Dis 2004, 63:1341-1343
31. Lassoued K, Saiag P, Anglade MC, Roujeau JC, Touraine RL: Failure of warfarin in treatment of calcinosis universalis. Am J Med 1988, 84:795-796
32. van Summeren MJ, Spliet WG, van Royen-Kerkhof A, Vermeer C, Lilien M, Kuis W, Schurgers LJ: Calcinosis in juvenile dermatomyositis: a possible role for vitamin K-dependent protein matrix Gla protein. Rheumatology (Oxford) 2008, 47:267-271
33. Uitto J, Jiang Q: Pseudoxanthoma elasticum-like phenotypes: more diseases than one. J Invest Dermatol 2007, 127:507-510
34. Borst P, van de Wetering K, Schlingemann R: Does the absence of ABCC6 (multidrug resistance protein 6) in patients with Pseudoxanthoma elasticum prevent the liver from providing sufficient vitamin K to the periphery? Cell Cycle 2008, 7:1575-1579
35. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997, 386:78-81
36. Parmar H, Blaser S, Unger S, Yoo SJ, Papsin B: Petrified ears in a patient with Keutel syndrome: temporal bone CT findings. Pediatr Radiol 2006, 36:241-243
37. Hur DJ, Raymond GV, Kahler SG, Riegert-Johnson DL, Cohen BA, Boyadjiev SA: A novel MGP mutation in a consanguineous family: review of the clinical and molecular characteristics of Keutel syndrome. Am J Med Genet A 2005, 135:36-40
38. Spronk HM, Soute BA, Schurgers LJ, Thijssen HH, De Mey JG, Vermeer C: Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. J Vasc Res 2003, 40:531-537
39. Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, Hofman A, Witteman JC: Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 2004, 134:3100-3105
40. Braam LA, Hoeks AP, Brouns F, Hamulyák K, Gerichhausen MJ, Vermeer C: Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. Thromb Haemost 2004, 91:373-380
41. Becker RC: Warfarin-induced vasculopathy. J Thromb Thrombolysis 2007, 23:79-81
42. Murshed M, Schinke T, McKee MD, Karsenty G: Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol 2004, 165:625-630